Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Change in Intangibles (2022)

Historic Change in Intangibles for ImmunityBio (IBRX) over the last 2 years, with Q1 2022 value amounting to $21.2 million.

  • ImmunityBio's Change in Intangibles changed N/A to $21.2 million in Q1 2022 from the same period last year, while for Dec 2022 it was $21.2 million, marking a year-over-year change of. This contributed to the annual value of $21.2 million for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q1 2022, ImmunityBio's Change in Intangibles is $21.2 million.
  • In the past 5 years, ImmunityBio's Change in Intangibles ranged from a high of $21.2 million in Q1 2022 and a low of $21.2 million during Q1 2022